Search Results - Blithe, Diana L
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
Pipeline for Contraceptive Development by Blithe, Diana L.
Published 2016Text -
2
-
3
Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal BMI women: a pilot study by Edelman, Alison B, Cherala, Ganesh, Li, Hong, Pau, Francis, Blithe, Diana L, Jensen, Jeffrey T
Published 2016Text -
4
Simultaneous assay of segesterone acetate (Nestorone®), estradiol, progesterone, and estrone in human serum by LC-MS/MS by Erikson, David W., Blue, Steven W., Fecteau, Kristopher M., Edelman, Alison B., Jensen, Jeffrey T., Blithe, Diana L.
Published 2020Text -
5
Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation by Huang, Yongmei, Merkatz, Ruth B., Hillier, Sharon L., Roberts, Kevin, Blithe, Diana L., Sitruk-Ware, Régine, Creinin, Mitchell D.
Published 2015Text -
6
-
7
-
8
Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial(, , ) by Roth, Mara Y., Shih, Grace, Ilani, Niloufar, Wang, Christina, Page, Stephanie T., Bremner, William J., Swerdloff, Ronald S., Sitruk-Ware, Regine, Blithe, Diana L., Amory, John K.
Published 2014Text -
9
Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days by Thirumalai, Arthi, Yuen, Fiona, Amory, John K, Hoofnagle, Andrew N, Swerdloff, Ronald S, Liu, Peter Y, Long, Jill E, Blithe, Diana L, Wang, Christina, Page, Stephanie T
Published 2020Text -
10
A New Combination of Testosterone and Nestorone Transdermal Gels for Male Hormonal Contraception by Ilani, Niloufar, Roth, Mara Y., Amory, John K., Swerdloff, Ronald S., Dart, Clint, Page, Stephanie T., Bremner, William J., Sitruk-Ware, Regine, Kumar, Narender, Blithe, Diana L., Wang, Christina
Published 2012Text -
11
Effects of Combined Oral Contraceptives, Depot Medroxyprogesterone Acetate, and the Levonorgestrel-releasing Intrauterine System on the Vaginal Microbiome by Brooks, J. Paul, Edwards, David J., Blithe, Diana L., Fettweis, Jennifer M., Serrano, Myrna G., Sheth, Nihar U., Strauss, Jerome F., Buck, Gregory A., Jefferson, Kimberly K.
Published 2016Text -
12
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from phase 3 trials by Vieira, Carolina Sales, Fraser, Ian S., Plagianos, Marlena G, Burke, Anne E., Westhoff, Carolyn L., Jensen, Jeffrey, Brache, Vivian, Bahamondes, Luis, Merkatz, Ruth, Sitruk-Ware, Regine, Blithe, Diana L.
Published 2019Text -
13
Comparison of Metabolic Effects of the Progestational Androgens Dimethandrolone Undecanoate and 11β-MNTDC in Healthy Men by Yuen, Fiona, Thirumalai, Arthi, Fernando, Frances A., Swerdloff, Ronald S., Liu, Peter Y., Pak, Youngju, Hull, Laura, Bross, Rachelle, Blithe, Diana L., Long, Jill E., Page, Stephanie T., Wang, Christina
Published 2021Text -
14
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype by Nguyen, Brian T., Farrant, Maritza T, Anawalt, Bradley D., Yuen, Fiona, Thirumalai, Arthi, Amory, John K, Swerdloff, Ronald S., Bremner, William J, Liu, Peter Y., Blithe, Diana L., Page, Stephanie T., Wang, Christina
Published 2020Text -
15
Single, Escalating Dose Pharmacokinetics, Safety and Food Effects of a New Oral Androgen Dimethandrolone Undecanoate in Man: A prototype oral male hormonal contraceptive by Surampudi, Prasanth, Page, Stephanie T., Swerdloff, Ronald S., Nya-Ngatchou, Jean Jacques, Liu, Peter Y., Amory, John K., Leung, Andrew, Hull, Laura, Blithe, Diana L., Woo, Jason, Bremner, William J., Wang, Christina
Published 2014Text -
16
Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill by Thirumalai, Arthi, Ceponis, Jonas, Amory, John K, Swerdloff, Ronald, Surampudi, Vijaya, Liu, Peter Y, Bremner, William J, Harvey, Eric, Blithe, Diana L, Lee, Min S, Hull, Laura, Wang, Christina, Page, Stephanie T
Published 2018Text -
17
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial by Nguyen, Brian T., Yuen, Fiona, Farrant, Maritza, Thirumalai, Arthi, Fernando, Frances, Amory, John K., Swerdloff, Ronald S., Anawalt, Bradley D., Blithe, Diana L., Long, Jill E., Liu, Peter Y., Page, Stephanie T., Wang, Christina
Published 2021Text -
18
Contraceptive and Infertility Target DataBase: a contraceptive drug development tool for targeting and analysis of human reproductive specific tissues(†) by Sinha, Subarna, Knapp, Merrill, Pywtorak, John, McCain, Greg, Wingerden, Kenneth, VanDervoort, Colin, Gondek, J Mark, Madrid, Peter, Parman, Toufan, Gerrard, Stephen, Long, Jill E, Blithe, Diana L, Moss, Stuart, Lee, Min S
Published 2021Text -
19
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate by Chen, Melissa J., Creinin, Mitchell D., Turok, David K., Archer, David F., Barnhart, Kurt T., Westhoff, Carolyn L., Thomas, Michael A., Jensen, Jeffrey T., Variano, Bruce, Sitruk-Ware, Regine, Shanker, Anita, Long, Jill, Blithe, Diana L.
Published 2020Text -
20
Combined Nestorone-Testosterone Gel Suppresses Serum Gonadotropins to Concentrations Associated with Effective Hormonal Contraception in Men by Anawalt, Bradley D., Roth, Mara Y., Ceponis, Jonas, Surampudi, Vijaya, Amory, John K., Swerdloff, Ronald S., Liu, Peter Y., Dart, Clint, Bremner, William J., Sitruk-Ware, Regine, Kumar, Narender, Blithe, Diana L., Page, Stephanie T., Wang, Christina
Published 2019Text